We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1B
AUM Growth
+$81M
Cap. Flow
+$45.6M
Cap. Flow %
4.55%
Top 10 Hldgs %
62.52%
Holding
4,698
New
814
Increased
789
Reduced
1,481
Closed
1,566

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$213M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$157M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$63.3M
4
UWM icon
ProShares Ultra Russell2000
UWM
+$20.4M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$19.6M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$11.7M
3
XOM icon
ExxonMobil
XOM
+$10.9M
4
BAC icon
Bank of America
BAC
+$8.84M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.82M

Sector Composition

Rank Sector Weight
1 Financials 1.65%
2 Technology 1.48%
3 Materials 1.36%
4 Healthcare 1.28%
5 Industrials 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNOB icon
3151
Center Bancorp
CNOB
$1.78B
$0 ﹤0.01%
8
-1,015
-99% -$25.1K
CNS icon
3152
Cohen & Steers
CNS
$4.31B
– –
-184
Closed -$6K
CNTY icon
3153
Century Casinos
CNTY
$34.3M
– –
-748
Closed -$6K
CNVS icon
3154
Cineverse
CNVS
$64.9M
$0 ﹤0.01%
9
-36
-80% -$997
CNXN icon
3155
PC Connection
CNXN
$2.13B
– –
-105
Closed -$3K
COHU icon
3156
Cohu
COHU
$2.49B
– –
-1,648
Closed -$23K
COKE icon
3157
Coca-Cola Consolidated
COKE
$12.6B
– –
-1,150
Closed -$20K
COLB icon
3158
Columbia Banking Systems
COLB
$8.83B
– –
-3,582
Closed -$160K
COST icon
3159
Costco
COST
$420B
– –
-8,227
Closed -$1.32M
CPA icon
3160
Copa Holdings
CPA
$5.77B
– –
-697
Closed -$63K
CPF icon
3161
Central Pacific Financial
CPF
$1.01B
– –
-351
Closed -$11K
CPHC icon
3162
Canterbury Park Holding Corp
CPHC
$80M
$0 ﹤0.01%
8
-392
-98% -$4.04K
CPIX icon
3163
Cumberland Pharmaceuticals
CPIX
$115M
– –
-38
Closed –
CRAI icon
3164
CRA International
CRAI
$1.13B
– –
-155
Closed -$6K
CRBP icon
3165
Corbus Pharmaceuticals
CRBP
$184M
– –
-17
Closed -$4K
CRD.B icon
3166
Crawford & Co Class B
CRD.B
$593M
– –
-1,901
Closed -$24K
CRIS icon
3167
Curis
CRIS
$7.8M
– –
-6
Closed -$38K
CRSP icon
3168
CRISPR Therapeutics
CRSP
$5.19B
– –
-479
Closed -$10K
CRVL icon
3169
CorVel
CRVL
$3.23B
– –
-231
Closed -$3K
CRVO icon
3170
CervoMed
CRVO
$26.4M
– –
0
– -$1K
CRVS icon
3171
Corvus Pharmaceuticals
CRVS
$1.15B
– –
-1,427
Closed -$21K
CSGS
3172
DELISTED
CSG Systems International
CSGS
– –
-388
Closed -$19K
CSL icon
3173
Carlisle Companies
CSL
$15.4B
– –
-131
Closed -$14.1K
CSQ icon
3174
Calamos Strategic Total Return Fund
CSQ
$3.35B
– –
-1,674
Closed -$17K
CSR
3175
Centerspace
CSR
$952M
– –
-56
Closed -$4K
125 126
127
128 129

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2017 Portfolio in Review

As of Q1 2017, Tower Research Capital (TRC) held 4,698 positions worth $1B, up 8.8% from $921M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tower Research Capital (TRC) deployed $45.6M of net new capital in Q1 2017, opening 814 new positions and adding to 789 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 14% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Apple, an estimated $13.3M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2017 buy was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $213M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2017 reduction was Apple, cutting an estimated $13.3M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2017, selling an estimated $8.82M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 63% of its $1B portfolio in Q1 2017.
  • Tower Research Capital (TRC) opened 814 new positions and closed 1,566 in Q1 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.